Literature DB >> 27246364

An eco-friendly direct spectrofluorimetric method for the determination of irreversible tyrosine kinase inhibitors, neratinib and pelitinib: application to stability studies.

H M Maher1,2, N Z Alzoman1, S M Shehata1.   

Abstract

A new rapid and simple stability-indicating spectrofluorimetric method has been developed for the determination of two irreversible tyrosine kinase inhibitors (TKIs), neratinib (NER) and pelitinib (PEL). The method is based upon measurement of the native fluorescence intensity of both drugs at λex 270 nm in aqueous borate buffer solutions (pH 10.5). The fluorescence intensity recorded at 545 nm (NER) and 465 nm (PEL) were rectilinear over the concentration range of 0.1-10 μg/mL for both drugs with a high correlation coefficient (r > 0.999). The proposed method provided low limits of detection and of quantitation of 0.07, 0.11 μg/mL (NER) and 0.02, 0.05 μg/mL (PEL), respectively. The method was successfully applied for the determination of NER and PEL in bulk powder. The proposed methods were fully validated as per the International Conference on Harmonisation (ICH) guidelines. The application of the method was extended to stability studies of both NER and PEL under different forced-degradation conditions (acidic-induced, base-induced, oxidative, wet heat, and photolytic degradation). Moreover, the kinetics of the base-induced and oxidative degradation of both drugs was investigated and the pseudo-first-order rate constants and half-lives were estimated at different temperatures. Also, an Arrhenius plot was applied to predict the stability behaviour of the two drugs at room temperature.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  degradation kinetics; neratinib; pelitinib; spectrofluorimetry; stability studies

Mesh:

Substances:

Year:  2016        PMID: 27246364     DOI: 10.1002/bio.3160

Source DB:  PubMed          Journal:  Luminescence        ISSN: 1522-7235            Impact factor:   2.464


  2 in total

1.  LC-MS/MS assay for the quantitation of the tyrosine kinase inhibitor neratinib in human plasma.

Authors:  Brian F Kiesel; Robert A Parise; Alvin Wong; Kiana Keyvanjah; Samuel Jacobs; Jan H Beumer
Journal:  J Pharm Biomed Anal       Date:  2016-11-22       Impact factor: 3.935

2.  Experimental and Computational Evaluation of Chloranilic Acid as an Universal Chromogenic Reagent for the Development of a Novel 96-Microwell Spectrophotometric Assay for Tyrosine Kinase Inhibitors.

Authors:  Ibrahim A Darwish; Hany W Darwish; Nasr Y Khalil; Ahmed Y A Sayed
Journal:  Molecules       Date:  2021-01-31       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.